CHDI FOUNDATIONCHDI

Accelerating Therapeutic Development for Huntington's Disease

  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2026 Presentations
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel
  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2026 Presentations
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel

Marcus Munafò (http://www.bristol.ac.uk/expsych/people/marcus-r-munafo/) is Professor of Biological Psychology in the School of Experimental Psychology at the University of Bristol, Director of the Tobacco and Alcohol Research Group (http://www.bristol.ac.uk/expsych/research/brain/targ/), and an affiliate member of the Meta-Research Innovation Center (METRICS; http://metrics.stanford.edu/) at Stanford University. His group is part of the UK Centre for Tobacco and Alcohol Studies, and the Medical Research Council Integrative Epidemiology Unit at the University of Bristol. His research focuses on understanding pathways into, and the consequences of, health behaviors and mental health, with a particular focus on tobacco and alcohol use. This work includes: 1) observational and genetic epidemiology; 2) the laboratory study of cognitive and neurobiological mechanistic pathways; and 3) the development of novel individual- and population-level interventions that target these mechanisms. He has received a number of awards, including the British Psychological Society Health Psychology Early Career Award, the Society for Research on Nicotine and Tobacco Young Investigator Award, an American Cancer Society Union Internationale Contre Cancer Fellowship, the European College of Neuropsychopharmacology Fellowship Award, the British Association of Psychopharmacology Award, and the British Association of Psychopharmacology Cambridge Cognition Award. He has a long-standing interest in factors influencing the robustness of scientific findings, with a particular focus on the impact of low statistical power, and the incentive structures that shape the behavior of scientists.
Connect with CHDI

Send Feedback

We appreciate any comments or questions on this page—our goal is to make this concise and helpful.

[contact-form]
Join Our Mailing List
Terms of Use
Privacy Policy
Cookie Policy
Creative Commons License
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 Unported License.

Click to read a letter from Robert Pacifici, CHDI CSO, regarding COVID-19